ESMO Courses in Medical Oncology for Medical Students
The Medical Oncology Course for Students will take place in Naples and Valencia in 2019
The Medical Oncology Course for Students will take place in Naples and Valencia in 2019
The novel EHA/EBMT grading of ICAHT closely reflects the extent of hematological toxicity following BCMA- and CD19-directed CAR-T therapy.Severe ICAHT was
Joshua J. Meeks, MD, PhD, discusses effectively implementing recent therapeutic advances across the disease continuum of bladder cancer.
In a Chinese study, investigators found that sequential CD7 CAR T-cell therapy and allogeneic hematopoietic stem cell transplantation (HSCT) without graft-vs-host disease (GVHD) prophylaxis was…
An abstract is unavailable.
Treatment with autologous HER2-specifc CAR T cells was considered tolerable and produced responses in a phase 1 trial of patients with advanced sarcoma.
Liposomal irinotecan produced similar survival results as topotecan when used as second-line therapy in patients with SCLC.
After noticing a lump on the side of his neck, Judd Woehrle came to MD Anderson for oropharyngeal cancer treatment. Here’s how robotic surgery and…
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
The phase III RESILIENT Part 2 trial has shown no overall survival benefit with second-line liposomal irinotecan vs topotecan in patients with small cell lung…
Altering or increasing the dosage of smoking cessation regimens may help patients quit smoking, according to results from a recent sequential multiple-assignment randomized trial.